The $1 billion linkurl:life sciences initiative;http://www.the-scientist.com/news/display/53359/ posed by Massachusetts Governor Deval Patrick is dealing with some scrutiny lately. The new president of the Massachusetts Biotechnology Council faces a state ethics investigation about his transition from the public to the private sector, and has declined to publicly discuss the bill. Massachusetts Biotechnology Council President Robert Coughlin has announced he will not publicly discuss the bill, since, as a former state employee (he was a state representative from Dedham and the governor's undersecretary of business development) he cannot lobby the legislature until next year, according to the Boston Globe. He said he plans to avoid lobbying the state government until September, one year after he joined the council, and will focus his lobbying at the federal level, where he has no restrictions. Also linkurl:according to;http://www.boston.com/business/globe/articles/2007/11/30/for_biotech_chief_mums_the_word?mode=PF the Globe, Coughlin continued acting as Patrick's point person on the life sciences initiative without...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
